Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AG06474 for evoked pain in healthy participants
NCT06077786Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lu ag06474 in pain (4 arms), sponsored by Lundbeck. Primary endpoints: Change From Baseline in Pain Detection Thresholds (PDTs) for the UVB Heat Pain Test, Change From Baseline in Pain Detection Thresholds (PDTs) for the Capsaicin Heat Pain Test and 3 more. Started Oct 2023; status: completed.
02
Drugs
lu ag06474
03
Conditions
pain
Beyond the preview
Go deeper on NCT06077786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06077786.